Crossmark

Correction: Disruptions in Tiopronin therapy: impacts on clinical outcomes of pediatric cystinuria patients during the COVID-19 pandemic

Crossref DOI link: https://doi.org/10.1007/s00240-025-01802-4

Published Online: 2025-06-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Önal, Hülya Gözde https://orcid.org/0000-0002-3691-0933
Nalçacioğlu, Hülya https://orcid.org/0000-0002-0686-9714
Karali, Demet Tekcan https://orcid.org/0000-0001-7013-1354
Bilgici, Meltem Necibe Ceyhan https://orcid.org/0000-0002-0133-0234
Aydog, Ozlem https://orcid.org/0000-0002-2157-7226
Özkaya, Ozan https://orcid.org/0000-0002-0198-1221
Özden, Ender https://orcid.org/0000-0003-3196-4024
Sarikaya, Saban https://orcid.org/0000-0003-3479-2002
License Information

Text and Data Mining valid from 2025-06-25

Version of Record valid from 2025-06-25
More Information

Article History

First Online: 25 June 2025